| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-10 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.24 | 7e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |